Institut Pasteur-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Institut Pasteur - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014020
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology and chemistry, and virology, among others. It provides health services through its medical centers having vaccination center and outpatient department. Institut Pasteur offers educational services including Institut Pasteur courses, international network courses and doctoral programs. The institute partners with research institutes, private foundations, international organizations, universities academic organizations, associations, and bilateral and multilateral initiatives. Institut Pasteur is headquartered in Paris, France.

Institut Pasteur – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Pasteur, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Pasteur, Medical Devices Deals, 2011 to YTD 2017 9
Institut Pasteur, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Pasteur, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
MRC Technology Enters into Co-Development Agreement with IPS-CAS 13
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 14
Institut Pasteur Korea Enters into Research Agreement with DNDi 15
Ferring Pharma Partners with Institut Pasteur 16
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 17
Institut Pasteur Korea and DNDi Enter into Research Agreement 18
Amsterdam Molecular Therapeutics Enters Into An Agreement With Institut Pasteur And The Consortium 19
Licensing Agreements 20
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 20
Institut Pasteur Enters into Licensing Agreement with Stragen Pharma 21
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 22
Bluebird bio Amends its Licensing Agreement with Institut Pasteur 23
Institut Pasteur Enters Into Licensing Agreement With Stragen Pharma For Opiorphin 24
Institut Pasteur – Key Competitors 25
Institut Pasteur – Key Employees 26
Institut Pasteur – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Government and Public Interest 29
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 29
Aug 29, 2016: Alzheimer’s: Nicotinic receptors as a new therapeutic target 31
Other Significant Developments 32
Sep 07, 2016: Myriad RBM’s TruCulture and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Institut Pasteur, Pharmaceuticals & Healthcare, Key Facts 2
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Pasteur, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Pasteur, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Pasteur, Medical Devices Deals, 2011 to YTD 2017 9
Institut Pasteur, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
MRC Technology Enters into Co-Development Agreement with IPS-CAS 13
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 14
Institut Pasteur Korea Enters into Research Agreement with DNDi 15
Ferring Pharma Partners with Institut Pasteur 16
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 17
Institut Pasteur Korea and DNDi Enter into Research Agreement 18
Amsterdam Molecular Therapeutics Enters Into An Agreement With Institut Pasteur And The Consortium 19
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 20
Institut Pasteur Enters into Licensing Agreement with Stragen Pharma 21
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 22
Bluebird bio Amends its Licensing Agreement with Institut Pasteur 23
Institut Pasteur Enters Into Licensing Agreement With Stragen Pharma For Opiorphin 24
Institut Pasteur, Key Competitors 25
Institut Pasteur, Key Employees 26
Institut Pasteur, Subsidiaries 27

★海外企業調査レポート[Institut Pasteur-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nova Ljubljanska banka d.d.:企業の戦略・SWOT・財務分析
    Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report Summary Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, m …
  • Essel Propack Limited:戦略・SWOT・企業財務分析
    Essel Propack Limited - Strategy, SWOT and Corporate Finance Report Summary Essel Propack Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ImaginAb Inc:医療機器:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …
  • ESI Group S.A. (ESI):企業の財務・戦略的SWOT分析
    ESI Group S.A. (ESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kansas City Power & Light Co:企業の発電所・SWOT分析2018
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Foundation Medicine Inc (FMI)-医療機器分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Randstad Holding NV (RAND):企業の財務・戦略的SWOT分析
    Randstad Holding NV (RAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Leonardo S.p.A.:企業の戦略・SWOT・財務情報
    Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • InSightec Ltd:企業の製品パイプライン分析2018
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • NATS Holdings Limited:企業の戦略・SWOT・財務情報
    NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bannerman Resources Ltd (BNNLF):企業の財務・戦略的SWOT分析
    Summary Bannerman Resources Ltd (Bannerman) is a mining and mineral exploration and development company. The company carries out the business of acquisition, exploration, and development of uranium properties. It holds interest in Etango Uranium Project located in Namibia near Rio Tinto’s Rossing ur …
  • Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析
    Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Statnett SF:電力:M&Aディール及び事業提携情報
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • T-Mobile US Inc (TMUS):企業の財務・戦略的SWOT分析
    T-Mobile US Inc (TMUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Duke Energy Corp:企業の発電所・SWOT分析2018
    Duke Energy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Victek Co., Ltd.:企業の戦略・SWOT・財務分析
    Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆